Heterocyclic compounds and methods of use
US10183015B2 · kind B2 · utility
0Cited by
9References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2016 |
| Grant date | Jan 22, 2019 |
| Priority date | — |
| Expiry date | Mar 3, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides compounds and methods of using those compounds to treat liver fibrosis, including liver fibrosis which is a precursor to, is concurrent with, is associated with, or is secondary to nonalcoholic steatohepatitis (NASH); elevated cholesterol levels, and insulin resistance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.